📰 Contract Development News
Page 39 - Contract Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Contract Development. Real-time updates on events, politics, business and more.
April 4, 2023
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced it signed a service agreement with The Jikei University in Japan. Under the agreement
April 4, 2023
/PRNewswire/ -- Global private investment firm, Bridgewest Group, recognized for developing innovative companies in life sciences, software, and deep tech,...
April 4, 2023
INTRODUCTION. Over the years, rising complexity of active pharmaceutical ingredients (APIs) has led to the development of a myriad of novel formulations...
April 3, 2023
Manufacturing LBPs at industrial scale involves equipment and processing methods that can vary from those at development and semi-industrial scale. Sacco System can support your project all the way to commercial manufacture.
April 3, 2023
PolyPeptide Group / Key word(s): Personnel PolyPeptide appoints Juan-José Gonzalez as CEO and announces change of CFO 03-Apr-2023 / 07:0...
April 3, 2023
NorthStar’s Mo-99 program continues at the forefront of U.S. radioisotope production as the only commercialized producer of key medical radioisotopes molybdenum-99 (Mo-99)/technetium-99m (Tc-99m
April 2, 2023
Orgenesis Inc. (NASDAQ:ORGS – Get Rating) was the recipient of a significant decrease in short interest during the month of March. As of March 15th, there was short interest totalling 304,800 shares, a decrease of 19.1% from the February 28th total of 376,800 shares. Based on an average daily volume of 70,300 shares, the days-to-cover […]
March 31, 2023
This year’s Pros to Know winners are leading the pack in terms of innovation, enhancement and providing problem-solving solutions to the supply chain.
March 30, 2023
RoslinCT and Lykan Bioscience, leaders in ground-breaking Contract Development and Manufacturing for cell therapies, are delighted to announce that following a successful inspection at their Edinburgh, UK facility, from the Medicines and Healthcare...
March 30, 2023
TheracosBio recently received FDA approval for Brenzavvy (bexagliflozin), an oral sodium-glucose cotransporter 2 (SGLT2) inhibitorPiramal supported TheracosBio with starting materials, active